Miguel A Sanz Selected Research

Transplantation

4/2024	Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies.
1/2023	T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.
12/2020	Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.
1/2020	Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
1/2020	Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.
4/2019	Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen.
6/2017	Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia.
2/2016	Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.
1/2016	Advances in haploidentical stem cell transplantation for hematologic malignancies.
5/2015	The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel A Sanz Research Topics

Disease

51	Acute Promyelocytic Leukemia 11/2023 - 02/2004
38	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 04/2005
22	Leukemia 12/2021 - 09/2003
13	Neoplasms (Cancer) 05/2021 - 07/2002
12	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 06/2003
12	Infections 12/2020 - 07/2002
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 06/2003
10	Hemorrhage 01/2020 - 10/2005
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2017 - 02/2008
7	Fever (Fevers) 10/2011 - 07/2002
6	Multiple Myeloma 02/2015 - 02/2009
4	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2007
4	Residual Neoplasm 01/2018 - 01/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 03/2007
3	Mycoses (Diseases, Fungus) 09/2019 - 08/2006
3	Neutropenia 06/2010 - 07/2002
3	Febrile Neutropenia 04/2009 - 07/2002
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2023 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 05/2021 - 01/2011
2	Virus Diseases (Viral Diseases) 12/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2020 - 01/2007
2	Sepsis (Septicemia) 04/2015 - 12/2005
2	Drug-Related Side Effects and Adverse Reactions 03/2014 - 10/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2012 - 12/2006
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2012 - 09/2009
2	Thrombotic Thrombocytopenic Purpura 12/2010 - 10/2002
2	Blast Crisis (Blast Phase) 11/2010 - 11/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2010 - 11/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2010 - 11/2003
2	Multiple Sclerosis 11/2009 - 10/2008
2	Tumor Lysis Syndrome 01/2008 - 09/2003
2	Lymphoma (Lymphomas) 08/2006 - 09/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2023
1	Thrombotic Microangiopathies 05/2021

Drug/Important Bio-Agent (IBA)

37	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 02/2004
21	AnthracyclinesIBA 01/2019 - 02/2004
12	Arsenic Trioxide (Trisenox)FDA Link 12/2021 - 09/2005
11	Busulfan (Busulfex)FDA Link 05/2024 - 06/2003
8	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2008
7	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2021 - 02/2008
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021 - 06/2003
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2018 - 04/2008
5	fludarabineIBA 05/2018 - 04/2015
5	Melphalan (Alkeran)FDA LinkGeneric 04/2015 - 02/2009
4	romiplostim FDA Link 05/2012 - 02/2008
3	fms-Like Tyrosine Kinase 3IBA 06/2022 - 12/2014
3	Monoclonal AntibodiesIBA 01/2022 - 11/2004
3	Retinoic Acid Receptor alphaIBA 12/2021 - 04/2010
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2021 - 09/2013
3	midostaurinIBA 01/2021 - 01/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 05/2008
3	Protein Isoforms (Isoforms)IBA 11/2015 - 10/2011
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2015 - 09/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 04/2015 - 10/2011
3	Drug CombinationsIBA 08/2014 - 10/2013
3	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2010 - 10/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2009 - 07/2002
3	EnzymesIBA 07/2007 - 12/2006
3	AminoglycosidesIBA 12/2005 - 07/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2021 - 05/2015
2	Sirolimus (Rapamycin)FDA Link 05/2021 - 11/2020
2	Prednisone (Sone)FDA LinkGeneric 12/2020 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2007
2	AntigensIBA 01/2020 - 01/2006
2	AnticoagulantsIBA 01/2020 - 01/2007
2	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 10/2010
2	plerixafor FDA Link 05/2018 - 01/2018
2	nuclear pore complex protein 98IBA 11/2014 - 01/2011
2	Fluconazole (Zonal)FDA LinkGeneric 04/2012 - 09/2007
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2011 - 03/2007
2	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 04/2009 - 05/2005
2	GlycopeptidesIBA 04/2009 - 12/2005
2	CreatinineIBA 04/2008 - 08/2006
2	Allopurinol (Remid)FDA LinkGeneric 01/2008 - 09/2003
2	Cytochrome P-450 CYP3AIBA 07/2007 - 03/2007
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2007 - 03/2007
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 07/2007 - 03/2007
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 05/2005 - 07/2002
2	beta-LactamsIBA 05/2005 - 07/2002
2	Amikacin (A.M.K)FDA LinkGeneric 05/2005 - 07/2002
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 05/2024
1	thymoglobulin FDA Link 04/2024
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 11/2023
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	Azacitidine (5 Azacytidine)FDA Link 05/2022
1	Decitabine FDA Link 05/2022
1	CalicheamicinsIBA 01/2022
1	Gemtuzumab (Mylotarg)FDA Link 01/2022
1	BI 6727IBA 08/2021
1	Phosphotransferases (Kinase)IBA 08/2021

Therapy/Procedure

34	Therapeutics 04/2023 - 07/2002
33	Drug Therapy (Chemotherapy) 04/2023 - 01/2002
24	Transplantation 04/2024 - 01/2004
14	Stem Cell Transplantation 05/2024 - 08/2006
7	Hematopoietic Stem Cell Transplantation 01/2023 - 06/2003
3	Aftercare (After-Treatment) 01/2020 - 09/2008
2	Salvage Therapy 11/2019 - 02/2009
2	Cell Transplantation 11/2017 - 03/2016
2	Remission Induction 04/2010 - 04/2008